Summer Sale Get Elite for just $199.50 Claim Now

NovaBridge Biosciences

Contributing Author

Recent Articles by NovaBridge Biosciences

Jun-29	NovaBridge Biosciences Appoints Dr. Srishti Gupta as Chief Executive Officer NBP +20.73% GlobeNewswire
Jun-16	NovaBridge Biosciences Receives FDA Fast Track Designation for Givastomig in First-Line HER2-Negative Metastatic Gastric Cancer NBP GlobeNewswire
May-28	NovaBridge to Present at the 2026 Jefferies Global Healthcare Conference NBP GlobeNewswire
May-12	NovaBridge to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference NBP GlobeNewswire
Apr-22	NovaBridge Appoints Mark Hagler as President and Chief Commercial Officer to Advance Commercial Strategy and Maximize Pipeline Value NBP GlobeNewswire
Apr-07	NovaBridge Reports Full Year 2025 Financial Results and Provides Business Update NBP GlobeNewswire
Mar-16	NovaBridge Announces Productive FDA Type B Meeting on Potential Accelerated Approval Pathway for Givastomig in Gastric Cancer NBP GlobeNewswire
Mar-09	NovaBridge and Visara Announce Positive Results from VIS-101 Phase 2a Wet AMD Study NBP GlobeNewswire
Mar-03	NovaBridge to Host Business Update Call to Review Phase 2a Data for VIS-101 in Wet AMD on Monday, March 9, 2026 NBP -7.25% GlobeNewswire
Mar-02	NovaBridge to Present at the Leerink Partners 2026 Global Healthcare Conference NBP +5.18% GlobeNewswire
Feb-19	NovaBridge Appoints Biotech Leader, Emmett T. Cunningham, Jr, MD, PhD, MPH, as Vice Chairman of the Board to Further Accelerate Global Biotech Platform NBP GlobeNewswire
Feb-17	NovaBridge Doses First Patient in Global, Randomized Phase 2 Study of Givastomig Combined with Immunochemotherapy in Patients with 1L Metastatic Gastric Cancer NBP GlobeNewswire
Jan-20	NovaBridge Announces Open Market Purchases by Executive Chairman, Fu Wei NBP +5.09% GlobeNewswire
Jan-06	NovaBridge Presents Positive Givastomig Dose Expansion Data from the Phase 1b Combination Study in Patients with 1L Metastatic Gastric Cancer NBP -11.21% GlobeNewswire
Dec-30	NovaBridge to Ring the Nasdaq Opening Bell on Friday, January 2, 2026 NBP GlobeNewswire
Dec-10	NovaBridge Presents Positive Ragistomig Phase 1 Dose Expansion Data at ESMO-IO NBP GlobeNewswire
Dec-03	NovaBridge Announces Presentation of Ragistomig Expanded Phase 1 Data at ESMO-IO NBP GlobeNewswire
Nov-20	NovaBridge's Visara Subsidiary Appoints Distinguished Ophthalmology Leaders as Chief Medical Officer and Scientific Advisory Board Chair to Drive VIS-101 Forward NBP GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)